Amyloid PET May Influence Care of Patients With Cognitive Problems
“One thing that this study is not capturing is the meaning of diagnosis,” said Dr. Rabinovici. “Patients want to know what is going on in their brain. They want to understand what the cause of cognitive impairment is…. A lot of times, the uncertainty is worse than the certainty, even when the information is bad news.”
—Erik Greb
Suggested Reading
Jack CR Jr, Barrio JR, Kepe V. Cerebral amyloid PET imaging in Alzheimer’s disease. Acta Neuropathol. 2013; 126(5):643-657.
Johnson KA, Minoshima S, Bohnen NI, et al. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association. Alzheimers Dement. 2013;9(1):e-1-16.
Vandenberghe R, Adamczuk K, Van Laere K. The interest of amyloid PET imaging in the diagnosis of Alzheimer’s disease. Curr Opin Neurol. 2013;26(6):646-655.
